RA

Reyaz Ahmad Ansari

Active Director Director DIN 09619124
DIN 09619124 First appointment May 2022 Primary industry Non-Profit Organizations
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Reyaz Ahmad Ansari

Data last updated:

Reyaz Ahmad Ansari is a Director at Bionek Pharmaceuticals Private Limited (since 2022). The company operates in Non-Profit Organizations. Bionek Pharmaceuticals Private Limited reported revenue of ₹12.8 Lakh (FY 2025).

DIN 09619124
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 25 May 2022
Oldest Company Age 6 yrs
Largest company Bionek Pharmaceuticals Private Limited · ₹12.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 May 20222020₹12.8 Lakh (FY 2025)Active

Board colleagues of Reyaz Ahmad Ansari

Directorship timeline

Open interactive timeline →
Bionek Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Reyaz Ahmad Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reyaz Ahmad Ansari

Reyaz Ahmad Ansari currently holds 1 directorship: Bionek Pharmaceuticals Private Limited (Director, since 25 May 2022, revenue ₹12.8 Lakh (FY 2025)).

Reyaz Ahmad Ansari was first appointed on 25 May 2022 as Director at Bionek Pharmaceuticals Private Limited.

The current boards of Reyaz Ahmad Ansari's companies include Abdul Wafa Ansari (Bionek Pharmaceuticals Private Limited), Faiyaz Ahmed (Bionek Pharmaceuticals Private Limited), Iftekhar Ahmad (Bionek Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available